| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |